Theravance 8-K 2006
QuickLinks -- Click here to rapidly navigate through this document
Current Report Pursuant
Date of Report (Date of earliest event Reported): January 30, 2006
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
The information in this Item 7.01 and in the accompanying exhibit shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be specifically set forth by specific reference in such filing.
On January, 30, 2006, Theravance, Inc. filed an automatically effective registration statement on Form S-3 with the Securities and Exchange Commission, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INDEX TO EXHIBITS